Gerresheimer’s 100 millionth applicator for Organon contraceptive implant

Applicator produced in series since 2008

0
51
Gerresheimer
By dividing its product portfolio into three performance levels – Gx Value, Gx Advance and Gx Elite – Gerresheimer has created a standardized structure for its product platforms for bulk and presterilized 'ready-to-fill' primary packaging.

Gerresheimer, a system and solution provider and global partner to the pharma and biotech industries, recently produced at its Pfreimd location in Germany the 100 millionth sub-assembly for the current applicator for the Nexplanon contraceptive implant, a hormonal contraceptive from Organon.

Ever since the first clinical samples were manufactured for the market authorization of Nexplanon in 2006, the company has been working with Gerresheimer to produce the accompanying applicator. Developed by Gerresheimer and Organon, this applicator has been produced in series since 2008. 

Since the start of production, Gerresheimer has manufactured 100 million applicators on ultra-modern, automated production systems in Pfreimd. This collaboration with Organon is an example of how Gerresheimer supports pharma companies with containment solutions and drug delivery systems throughout the entire product life cycle – from the development of clinical samples to industrial production and continuous optimization.

The first birth control pill was sold in Germany on June 1, 1961. Besides the pill, there are now other hormonal contraceptive methods such as the contraceptive patch, the vaginal ring, the contraceptive injection, copper IUDs, and contraceptive implants. 

Globally active pharma company Organon was one of the first to produce the birth control pill. Organon’s vision is ‘a better and healthier every day for every woman.’ The range of hormonal contraceptives developed by Organon includes the Nexplanon contraceptive implant. The implant is inserted under the skin of the inner upper arm using an accompanying applicator. The active agent etonogestrel, a progesterone, is released steadily over a period of three years.

Clinical samples for market authorization

Gerresheimer has been working very closely with Organon ever since 2005. Back then, the first clinical samples of Nexplanon were developed along with the accompanying applicator for market authorization. At Gerresheimer in Pfreimd, where medical systems have been produced using plastic for over 50 years, 100 million of these applicators were manufactured on four in-house assembly systems and delivered from market authorization until today.

Entire applicator production chain in Pfreimd

Seven of the nine necessary applicator components are produced by Gerresheimer in Pfreimd, while two components are supplied parts. Gerresheimer in Pfreimd takes care of the entire production chain of the applicator, from injection molding, to assembly, inspection, all the way to packaging for Organon.

LEAVE A REPLY

Please enter your comment!
Please enter your name here